Correlation Between Catalyst Pharmaceuticals and DT Cloud

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and DT Cloud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and DT Cloud into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and DT Cloud Acquisition, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and DT Cloud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of DT Cloud. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and DT Cloud.

Diversification Opportunities for Catalyst Pharmaceuticals and DT Cloud

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Catalyst and DYCQ is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and DT Cloud Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DT Cloud Acquisition and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with DT Cloud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DT Cloud Acquisition has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and DT Cloud go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and DT Cloud

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 7.21 times more return on investment than DT Cloud. However, Catalyst Pharmaceuticals is 7.21 times more volatile than DT Cloud Acquisition. It trades about 0.04 of its potential returns per unit of risk. DT Cloud Acquisition is currently generating about 0.07 per unit of risk. If you would invest  2,260  in Catalyst Pharmaceuticals on March 19, 2025 and sell it today you would earn a total of  93.00  from holding Catalyst Pharmaceuticals or generate 4.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  DT Cloud Acquisition

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
DT Cloud Acquisition 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in DT Cloud Acquisition are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental indicators, DT Cloud is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Catalyst Pharmaceuticals and DT Cloud Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and DT Cloud

The main advantage of trading using opposite Catalyst Pharmaceuticals and DT Cloud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, DT Cloud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DT Cloud will offset losses from the drop in DT Cloud's long position.
The idea behind Catalyst Pharmaceuticals and DT Cloud Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences